P3 SubQ active TED
Research payments
$763,949
Through program year 2025, $763,949 in research payments was reported against P3 SubQ active TED, across 15 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $15,650 | 1 |
| 2024 | Research | $748,299 | 14 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ovette Villavicencio Tucson, AZ Named on 2 payments
- Raghu Mudumbai Seattle, WA Named on 2 payments
- Vinay Aakalu Ann Arbor, MI Named on 2 payments
- Kimberly Cockerham San Diego, CA Named on 2 payments
- Michael Yen Houston, TX Named on 2 payments
- John Nguyen Morgantown, WV Named on 2 payments
- Chitra Choudhary Kansas City, KS Named on 2 payments
- Catherine Liu San Diego, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.